Startups and early-stage businesses in Europe often face challenges when seeking funding. Traditional equity financing can dilute ownership and control, while bank loans are often not viable due to lack of collateral or operating history. This funding gap inhibits the growth and scaling of innovative European ventures, which ultimately slows economic development and the advancement of transformative technologies and services.
Our venture debt fund addresses this issue by providing an alternative or complementary financing solution to traditional equity and bank financing. We offer flexible, non-dilutive financing to support the growth and expansion of promising start-ups and early-stage businesses. Our fund is designed to support ventures through their various growth stages, while preserving equity and control for founders.
We primarily focus on startups and early-stage businesses that have already demonstrated a viable product-market fit, robust business model and growth potential, including a roadmap to breakeven. This typically includes Seed to Series B stages, but we're open to evaluate ventures at different stages based on their unique attributes and potential.
€1 million to €3 million
We offer more than venture debt; our team is proficient in technology-driven sectors like FinTech, MedTech, AI, IoT, CleanTech, and SaaS, and our financial support extends to factoring, securing bank loans, and CFO services for strategic financial planning and risk management. We also guide businesses in exploring other financial options such as leasing, grants, R&D tax credits, and incentive schemes. Our vast network of industry leaders, advisors, and partners provides strategic insights and valuable connections, driving growth and innovation in Europe's most promising ventures.
Venture debt financing provides startups with the necessary capital to achieve profitability without diluting equity. This enables companies to cover operating expenses, invest in growth, and reach positive cash flow, all while preserving control and ownership for founders and early investors.
Venture debt is a more cost-effective alternative to equity financing, as it carries lower interest rates and does not require startups to give up ownership stakes. This allows companies to retain a larger share of future profits and maintain greater decision-making control.
Venture debt extends a startup's financial runway by providing additional funds for growth, while not impacting the ownership structure. This helps companies navigate through periods of uncertainty, capitalize on market opportunities, or bridge the gap to the next fundraising round.
Utilizing venture debt financing helps startups preserve equity and reduce dilution for founders and existing shareholders. By borrowing capital rather than selling ownership stakes, companies can maintain control over strategic decision-making and benefit from future value creation.
A key advantage of venture debt financing is its sector-agnostic approach, which allows funds to invest in a wide range of industries and business models. This flexibility enables startups across various sectors to access capital and support their growth, regardless of the specific industry dynamics.
As a venture capital investor in digital health, we bring significant value to our portfolio companies through our extensive network of investors and startups in the health sector, providing valuable connections and resources for growth. Additionally, our access to partners enables strategic collaborations and market opportunities. This includes our partnership with CSS, Switzerland’s leading health insurer, which we support in the implementation of its investment activities under the brand of SwissHealth Ventures. With our deep understanding of the industry and track record of successful deals in the segment, we offer expertise and guidance to help our portfolio companies navigate the complex landscape and maximize their potential.